GTC Biotherapeutics Announces Filing Of Shelf Registration Statement

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Oct. 21, 2005--GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that it has filed a universal shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) pursuant to which the Company may issue up to an aggregate of $50 million of common stock, debt securities, and other types of securities. Proceeds from any offering under the shelf registration statement would provide flexibility in financing GTC's business needs, including funding for development and commercialization of its products and clinical programs as well as for general corporate purposes. The terms and price of any future offerings would be established at the time of the offering.